The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

(Reuters) -Cardiac diagnostic software maker Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in ...

Like waves crashing on the beach, med-tech IPOs keep on coming. Heartflow Inc. set terms for its IPO on Aug. 1, offering 12.5 ...

This briefing covers Heartflow's upcoming IPO aiming for a $1.32 billion valuation, research linking artificial sweeteners to ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S. initial public offering on Thursday, at a time when it looks to tap into ...

There’s a long list of late-stage VC-backed tech companies with strong customer bases that investors hope will be enticed to ...

Those companies will likely continue to be in the spotlight, but in conversations I had with several investors following ...

Toledo's profit forecast boost, Heartflow's IPO plans, research linking artificial sweeteners to less effective cancer ...

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges in achieving higher rates of adoption in the past.

(Updated - July 17, 2025 5:13 PM EDT) Heartflow (HTFL) has filed for a proposed Nasdaq IPO. The company describes itself as: "We have pioneered the use of software and AI to deliver a more accurate ...

Mountain View, California-based Heartflow posted a loss of $32.3 million for the three months ended March 31, compared with a loss of $20.9 million a year earlier, the IPO filing showed.